BOROSCI
Borosil Scientific share price & financials
- Price
- ₹160.75
- Market cap
- ₹1.1k Cr
- Sector
- Capital Goods
What Borosil Scientific Limited does
Borosil Scientific Limited manufactures laboratory glassware and consumables, laboratory instruments (under the LabQuest brand), process-science equipment such as reactors (via subsidiary Goel Scientific Glass Works), and pharmaceutical primary packaging in the form of glass ampoules and tubular glass vials sold to injectable-drug makers. It also produces borosilicate domestic glassware (serveware, drinkware and storage) under the Borosil name. The company was demerged from Borosil Ltd in December 2023 and listed separately in June 2024, though its laboratory-glassware operations trace back to Borosil's 1962 founding as India's pioneer of borosilicate glassware. It earns revenue selling these products to research institutes, pharmaceutical companies, industrial labs and academia across India and in 90+ export countries, distributed through a channel-partner and warehouse network.
Segments
- Scientific Segment
- Glassware Segment
- Manufacturing facilities
- 4 plants: Bharuch (Gujarat, laboratory glassware), Pune (Maharashtra, lab equipment/instrumentation), Nashik (Maharashtra, pharma primary packaging), Vadodara (Gujarat, process equipment via Goel Scientific)
- Employees
- 1,800+ colleagues
- Channel partners
- 150+ across India
- Warehouses
- 4 PAN-India (Bharuch mother warehouse plus North, East and South regional warehouses)
- Export footprint
- 90+ countries
- Product portfolio
- 4,000+ SKUs spanning laboratory glassware/consumables, lab equipment, process systems and pharma primary packaging
Quarterly results
Q1 FY27: revenue up 11.2%, net profit up 203.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 103 | 101 | 129 | 96 | 107 +4% | 121 +20% | 143 +11% | 107 +11% |
| EBITDA | 16 | 10 | 17 | 5 | 8 −49% | 17 +72% | 32 +94% | 8 +74% |
| Net profit | 9 | 4 | 9 | -4 | 3 −68% | 9 +103% | 27 +216% | 4 +203% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −13.1% 1Y
1Y: ₹144.12 on 10 Sept 2025 → ₹125.28. High ₹173.52 (30 Jun 2026), low ₹100.97 (27 Mar 2026).
Financials, as filed
Revenue grew 8.8% a year over 2 years, FY24 to FY26. Operating margin widened to 13.3%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹395 Cr | ₹438 Cr | ₹467 Cr |
| Operating profit | ₹46 Cr | ₹52 Cr | ₹62 Cr |
| Operating margin | 11.5% | 11.9% | 13.3% |
| Interest | ₹3 Cr | ₹2 Cr | ₹1 Cr |
| Depreciation | ₹16 Cr | ₹18 Cr | ₹19 Cr |
| Net profit | ₹23 Cr | ₹27 Cr | ₹35 Cr |
| Net margin | 5.9% | 6.1% | 7.4% |
| Cash from operations | ₹30 Cr | ₹120 Cr | ₹43 Cr |
| Free cash flow | ₹17 Cr | ₹106 Cr | ₹16 Cr |
| ROCE | — | 10.0% | 12.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Equity capital | ₹9 Cr | ₹9 Cr | ₹9 Cr |
| Reserves | ₹367 Cr | ₹396 Cr | ₹432 Cr |
| Borrowings | ₹18 Cr | ₹9 Cr | ₹9 Cr |
| Other liabilities | ₹95 Cr | ₹89 Cr | ₹90 Cr |
| Total liabilities | ₹488 Cr | ₹502 Cr | ₹540 Cr |
| Fixed assets | ₹192 Cr | ₹185 Cr | ₹189 Cr |
| Capital work in progress | ₹1 Cr | ₹2 Cr | ₹9 Cr |
| Investments | ₹0 Cr | ₹108 Cr | ₹122 Cr |
| Other assets | ₹295 Cr | ₹207 Cr | ₹220 Cr |
| Total assets | ₹488 Cr | ₹502 Cr | ₹540 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, the public trimmed −0.71 pp while promoters added +0.47 pp. The shareholder count shrank 8% to 53,712.
- Promoters
- 68.3%
- FIIs
- 0.2%
- DIIs
- 0.3%
- Public
- 31.2%
Since Jun 2025
- Public −0.71 pp
- Promoters +0.47 pp
- DIIs +0.21 pp
How it drifted, 9 quarters
Ownership split by quarter, oldest first. Jun '24: Promoters 67.9%, FIIs 0.4%, DIIs 0.1%, Public 31.5%.Sep '24: Promoters 67.9%, FIIs 0.4%, DIIs 0.0%, Public 31.7%.Dec '24: Promoters 67.8%, FIIs 0.3%, DIIs 0.0%, Public 31.9%.Mar '25: Promoters 67.8%, FIIs 0.2%, DIIs 0.0%, Public 31.9%.Jun '25: Promoters 67.8%, FIIs 0.2%, DIIs 0.1%, Public 31.9%.Sep '25: Promoters 67.8%, FIIs 0.1%, DIIs 0.1%, Public 32.0%.Dec '25: Promoters 67.8%, FIIs 0.1%, DIIs 0.2%, Public 31.9%.Mar '26: Promoters 68.1%, FIIs 0.1%, DIIs 0.3%, Public 31.6%.Jun '26: Promoters 68.3%, FIIs 0.2%, DIIs 0.3%, Public 31.2%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Shreevar Kheruka +0.19 pp 2.11% held
The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Borosil Scientific Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Kiran Kheruka | 25.52% | unchanged |
| Rekha Kheruka | 13.86% | unchanged |
| Pradeep Kumar Kheruka | 11.16% | unchanged |
| Croton Trading Private Limited | 11.04% | unchanged |
| Gujarat Fusion Glass LLP | 2.64% | unchanged |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | 2.21% | unchanged |
| Borosil Scientific Limited Unclaimed Securities Suspense Escrow Account | 2.17% | unchanged |
| Shreevar Kheruka | 2.11% | +0.19 pp |
| Dipak Kanayalal Shah | 1.08% | unchanged |
| Spartan Trade Holdings LLP | 0.97% | unchanged |
| Borosil Holdings Llp | 0.77% | unchanged |
| Associated Fabricators LLP | 0.20% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
AttractiveTo justify its price of ₹125, this stock must grow earnings at 19% every year for 7 years. Our analysis caps realistic growth at ~29%. At that growth it is worth ₹212 — upside of 69%.
- Growth the price implies
- 18.8% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 21.3% a year
- net profit, FY24–FY26 · EPS 29.2%
- The gap
- -0.1 pp
- 69% downside if it only repeats history
Learn to analyse Borosil Scientific Limited
Guides on how to read this kind of business and the numbers that matter.